OSTERWEIS CAPITAL MANAGEMENT INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
OSTERWEIS CAPITAL MANAGEMENT INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$7,351,338
+1.1%
72,171
+0.2%
0.54%
+12.1%
Q2 2023$7,271,676
+26.5%
72,061
+15.3%
0.48%
+23.0%
Q1 2023$5,747,976
+4.2%
62,478
+2.7%
0.39%
-2.5%
Q4 2022$5,517,862
+21.1%
60,823
+1.5%
0.40%
+17.3%
Q3 2022$4,555,000
-10.8%
59,921
-0.8%
0.34%
-10.5%
Q2 2022$5,104,000
-3.6%
60,376
+0.0%
0.38%
+31.3%
Q1 2022$5,296,000
-0.1%
60,354
-0.4%
0.29%
+9.8%
Q4 2021$5,299,000
-18.0%
60,576
-23.4%
0.26%
-24.9%
Q3 2021$6,466,000
-74.1%
79,067
-71.2%
0.35%
-72.6%
Q2 2021$25,006,000
+3.0%
274,065
-3.5%
1.29%
-2.8%
Q1 2021$24,276,000
-9.5%
283,995
+0.0%
1.32%
-17.3%
Q4 2020$26,815,000
+31.4%
283,970
+21.0%
1.60%
+16.1%
Q3 2020$20,401,000
-14.6%
234,605
-14.2%
1.38%
-20.5%
Q2 2020$23,879,000
-0.4%
273,399
-6.0%
1.73%
-11.0%
Q1 2020$23,970,000
-16.1%
290,724
-3.6%
1.95%
-1.5%
Q4 2019$28,562,000
+8.3%
301,639
-0.6%
1.98%
+2.7%
Q3 2019$26,374,000
-5.7%
303,505
-0.9%
1.92%
-2.6%
Q2 2019$27,963,000
-4.6%
306,245
+0.4%
1.98%
+7.7%
Q1 2019$29,320,000
-8.2%
304,973
-18.0%
1.83%
-25.3%
Q4 2018$31,928,000
-6.5%
372,073
-6.1%
2.46%
+12.6%
Q3 2018$34,157,000
-9.7%
396,438
-20.8%
2.18%
-10.9%
Q2 2018$37,828,000
-9.4%
500,778
-3.1%
2.45%
-17.6%
Q1 2018$41,770,000
-8.4%
516,638
-4.9%
2.97%
-8.2%
Q4 2017$45,607,000
-0.2%
543,208
+2.0%
3.24%
-5.6%
Q3 2017$45,712,000
-0.1%
532,468
-2.8%
3.43%
-1.6%
Q2 2017$45,738,000
+13.4%
547,955
+0.9%
3.48%
+10.4%
Q1 2017$40,334,000
+52.6%
543,070
+49.7%
3.16%
+65.6%
Q4 2016$26,428,000
-33.6%
362,818
-28.0%
1.90%
-20.4%
Q3 2016$39,772,000
-8.8%
503,703
-4.7%
2.39%
-13.9%
Q2 2016$43,599,000
-6.8%
528,404
-18.2%
2.78%
+2.2%
Q1 2016$46,771,000
+36.4%
645,654
+62.0%
2.72%
-14.0%
Q4 2015$34,301,000
-42.7%
398,666
-38.8%
3.16%
+16.6%
Q3 2015$59,846,000
-7.0%
651,065
-0.5%
2.71%
+20.7%
Q2 2015$64,367,000
-4.9%
654,535
-4.6%
2.24%
+3.7%
Q1 2015$67,659,000
+5.4%
686,130
-1.0%
2.16%
+2.8%
Q4 2014$64,206,000
-5.9%
692,925
-4.4%
2.10%
+0.5%
Q3 2014$68,203,000
+6.9%
724,559
+2.8%
2.10%
+14.7%
Q2 2014$63,829,000
+8.2%
705,059
+1.6%
1.83%
+1.1%
Q1 2014$59,001,000
+7.0%
693,969
+1.2%
1.81%
+5.9%
Q4 2013$55,128,000
+5.3%
685,849
+1.6%
1.71%
+0.9%
Q3 2013$52,373,000
+11.3%
675,345
+1.5%
1.69%
-3.8%
Q2 2013$47,038,000665,2301.76%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders